Raffles Medical Group

Stocking up on the future

SINGAPORE (Feb 4): The advent of another new year has us thinking about the future — specifically the future economy. From preschoolers to mid-career executives, corporate bosses to top civil servants, just about everybody is busy preparing for the disruptive force of technology, even though it is not clear exactly how businesses and the economy will be reshaped.

Bringing home the bacon

SINGAPORE (Feb 1): The Edge Singapore has assembled the annual portfolio of 10 stocks, done in conjunction with the Lunar New Year.

Raffles Medical Group's medical fees remain in the pink of health

SINGAPORE (Dec 5): UOB Kay Hian is reiterating its “buy” call on Raffles Medical Group with an increased target price of $1.30 from $1.27 previously.

This came on the back of the Ministry of Health (MOH) publishing its fee benchmark guidelines for surgical procedures to contain exorbitant fees in the private sector. The Fee Benchmark report noted that private inpatient bills grew at 9.0% per year (from 2007-2017) compared with 4.9% per year for Class A (public sector) inpatient bills.

Raffles Medical and China Taiping to collaborate on insurance, real estate

SINGAPORE (Aug 27): Mainboard-listed Raffles Medical Group could bring its insurance business to China.

On Monday, the healthcare operator signed a Memorandum of Understanding with insurer China Taiping to explore setting up a joint venture in China offering medical insurance and health management services.

Raffles Medical a potential beneficiary of new healthcare initiatives

SINGAPORE (Aug 21): Raffles Medical Group, which operates over 80 CHAS-approved clinics in Singapore, could see a lift in its local patient load given the new healthcare initiatives launched by the government.

See: PM Lee unveils healthcare and housing plans to curb cost of living pressures

Is it too early to go into Raffles Medical?

SINGAPORE (May 2): RHB is downgrading its call on Raffles Medical Group (RMG) to “sell” from “neutral” with an unchanged $1.02 target price.

The move comes on a number of factors including RMG’s recent share price run-up since the group’s release of its 4Q17 results, as well as expectations of potential headwinds such as start-up losses from its China operations.

Raffles Medical Group posts 1% increase in 3Q earnings to $16.4 mil

SINGAPORE (Oct 30): Raffles Medical Group (RMG) announced that 3Q17 earnings increased 1.0% to $16.4 million compared to $16.2 million in 3Q16.

Revenue for the third quarter ended September saw a slight 0.3% increase to $119.6 million compared to $119.3 million the same period last year.

This was due to the growth in revenue from the hospital services division of 3.1%, due mainly to by the increase in local patient load.

Raffles Medical cut to ‘sell’ on near-term support from non-core income, China startup losses

SINGAPORE (Aug 1): RHB and Maybank Kim Eng are downgrading their call on Raffles Medical Group to “sell” with target prices of $1.10 and $1.12 respectively.

The rating comes on the back of near-term earnings support coming from non-core rental income, structural decline in in domestic healthcare demand and losses in the group’s startup hospitals in China.

In a Tuesday report, Maybank analyst John Cheong says topline growth for Singapore remains weak at only 1% y-o-y for 2Q.

This Malaysia-based hospital operator is UOB’s top healthcare 'buy'

SINGAPORE (June 19): UOB Kay Hian is remaining “market weight” on Singapore’s healthcare sector on expectations of decelerating medical tourism growth in Singapore, due to rising competition from neighbouring Asean countries such as Malaysia. 

“Going forward, we expect patient growth [in Singapore] to stem largely from local patients, underpinned by favourable demographic trends such as ageing demographics as well as rising income levels,” says lead analyst Thai Wei Ying in a Monday report.

Rally in Singapore healthcare stocks may not be over

SINGAPORE (May 22): Healthcare stocks in Singapore have rewarded investors with an average 50% gain in the past year, a rally that may continue as companies acquire local clinics to expand in the region’s medical-care market.

Be informed of the stories that matter